Financhill
Back

Sage Therapeutics Stock Predictions

Sage Therapeutics Stock Forecast

  • Over the next 52 weeks, Sage Therapeutics has on average historically fallen by 4.4% based on the past 10 years of stock performance.
  • Sage Therapeutics has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Sage Therapeutics Stock Undervalued?
    The current Sage Therapeutics [SAGE] share price is $6.31. The Score for SAGE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • SAGE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Sage Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Sage Therapeutics has on average historically fallen by 4.4% based on the past 10 years of stock performance.

Sage Therapeutics Stock Rating

Sell
34
Sage Therapeutics (SAGE) is a Sell

Is Sage Therapeutics overpriced?

  • Sage Therapeutics has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Sage Therapeutics Stock Price History

Is SAGE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com

52-Week Data

52-Week High:
28.26
52-Week Low:
5.64

Prediction Charts

Market Cap:
386M
Price in USD:
6.31
Volume:
517.43K
Beta:
1.36

Technical Analysis

SMA50:
7.16
SMA100:
8.62
SMA200:
12.86
52-Wk Change:
-63.1%

Stock Predictions

  • Is Sage Therapeutics stock public?
    Yes, Sage Therapeutics is a publicly traded company.
  • What is the Sage Therapeutics stock quote today?
    The Sage Therapeutics stock price is 6.31 USD today.
  • How to buy Sage Therapeutics stock online?
    You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-23 7.59 7.65 7.72 7.33
Oct-24 7.68 7.85 7.95 7.57
Oct-25 7.89 8.01 8.16 7.84
Oct-28 8.10 8.54 8.62 8.10
Oct-29 8.53 8.49 8.70 8.34
Oct-30 7.69 6.46 7.97 6.20
Oct-31 6.39 6.09 6.59 5.92
Nov-1 6.09 6.05 6.16 5.84
Nov-4 5.92 5.81 6.12 5.80
Nov-5 5.67 5.94 5.95 5.64
Nov-6 6.27 5.95 6.44 5.93
Nov-7 5.96 6.32 6.42 5.86
Nov-8 6.33 6.31 6.39 6.17
Nov-11 6.46 6.31 6.65 6.29

Sage Therapeutics Earnings

Sage Therapeutics Earnings Report: Per Share Sage Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sage Therapeutics Forecast Revenue Growth

Sage Therapeutics Stock Analysis: Historical quarterly revenues per share for Sage Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.13 per share, and an increase next year of $2.22 per share.

* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.